Reconciling Pasteur and Darwin to control infectious diseases

PLoS Biology

Volumn 16, Issue 1, 2018, Pages

  Alizon, Samuel ^a   Méthot, Pierre Olivier ^b  

^a CNRS   (France)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL MICROBIOLOGY; COEVOLUTION; DRUG EFFICACY; GENE MUTATION; HOST PATHOGEN INTERACTION; HUMAN; INFECTION CONTROL; MICROBIOLOGY; MOLECULAR ECOLOGY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; NONHUMAN; PUBLIC HEALTH; VACCINATION; VIRULENCE; COMMUNICABLE DISEASE; EVOLUTION; GENETIC SELECTION; GENETICS;

ANTI-BACTERIAL AGENTS; BIOLOGICAL EVOLUTION; COMMUNICABLE DISEASES; DRUG RESISTANCE, MICROBIAL; HUMANS; SELECTION, GENETIC; VIRULENCE;

EID: 85041701482     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2003815     Document Type: Article

References (90)

1. Lederberg J, Pandemic as a natural evolutionary phenomenon. Social Research. 1988;55(3):343–359.
2. Bordier A, Les microbes et le transformisme. Bulletins de la Société d'anthropologie de Paris. 1888;11(1):743–779. doi: 10.3406/bmsap.1888.5406
3. Moulin AM. Darwinisme et pastorisme. In: Commémoration du centenaire de la mort de Charles Darwin, organisé dans le cadre des activités culturelles du comité d'entreprise de l'Institut Pasteur de Paris. Paris, France; 1982.Available from: https://hal.archives-ouvertes.fr/hal-00434433. Accessed on 11 January 2018.
4. Kolter R, Maloy S, Microbes and evolution: the world that Darwin never saw. Washington DC: ASM Press; 2012.
5. O'Malley MA, What did Darwin say about microbes, and how did microbiology respond?Trends Microbiol. 2009;17(8):341–7. doi: 10.1016/j.tim.2009.05.009 19679480
6. Darwin C, Darwin F, The life and letters of Charles Darwin, including an autobiographical chapter, Rev. John Murray; 1888.
7. Bynum WF, Darwin and the doctors: Evolution, diathesis, and germs in 19th-century Britain. Gesnerus. 1983;40(1–2):43–53. 6347824
8. Gayon J, Les premiers pastoriens et l'hérédité. Bulletin de la société d'histoire et d'épistémologie des sciences de la vie. 1995;2:193–204.
9. Mendelsohn JA, 'Like all that lives': Biology, medicine and bacteria in the age of Pasteur and Koch. Hist Philos Life Sci. 2002;24(1):3–36. 12664951
10. Burnet E, Microbes & toxins. New York, USA: G. P. Putnam's sons; 1912.
11. Nicolle C, Naissance, vie et mort des maladies infectieuses. Librairie Félix Alcan; 1930.
12. Pasteur L, Chamberlain CE, Roux E, Compte rendu sommaire des expériences faites à Pouilly-le-Fort, près Melun, sur la vaccination charbonneuse. Comptes-rendus des séances de l'Académie des Sciences. 1881;92:1378–83.
13. Farley J, The Social, political, and religious background to the work of Louis Pasteur. Ann Rev Microbiol. 1978;32(1):143–154. doi: 10.1146/annurev.mi.32.100178.001043 360963
14. Gayon J, Ruse M, Darwin and Darwinism in France before 1900. In: The Cambridge encyclopedia of Darwin and evolutionary thought. Cambridge University Press; 2013. p. 243–312.
15. Pichot A, Introduction générale. In: Écrits scientifiques et médicaux de Louis Pasteur. Paris, France: Flammarion; 2012. p. 7–18.
16. Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science. 2004;303(5656):327–32. doi: 10.1126/science.1090727 14726583
17. Roche B, Drake JM, Brown J, Stallknecht DE, Bedford T, Rohani P, Adaptive evolution and environmental durability jointly structure phylodynamic patterns in avian influenza viruses. PLoS Biol. 2014;12(8):e1001931. doi: 10.1371/journal.pbio.1001931 25116957
18. Neher RA, Bedford T, nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics. 2015;31(21):3546–3548. doi: 10.1093/bioinformatics/btv381 26115986
19. Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–72. doi: 10.1126/science.1259657 25214632
20. Holmes EC, Dudas G, Rambaut A, Andersen KG, The evolution of Ebola virus: Insights from the 2013–2016 epidemic. Nature. 2016;538(7624):193–200. doi: 10.1038/nature19790 27734858
21. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197–201. doi: 10.1126/science.1176225 19465683
22. Stadler T, Kühnert D, Rasmussen DA, du Plessis L, Insights into the early epidemic spread of ebola in Sierra Leone provided by viral sequence data. PLoS Curr. 2014;(1). doi: 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f 25642370
23. Saulnier E, Gascuel O, Alizon S, Inferring epidemiological parameters from phylogenies using regression-ABC: A comparative study. PLoS Comput Biol. 2017;13(3):e1005416. doi: 10.1371/journal.pcbi.1005416 28263987
24. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):e263. doi: 10.1371/journal.pmed.0030263 16700631
25. Gonzalez A, Ronce O, Ferriere R, Hochberg ME, Evolutionary rescue: An emerging focus at the intersection between ecology and evolution. Philos Trans R Soc Lond B. 2013;368(1610). doi: 10.1098/rstb.2012.0404 23209175
26. Hartfield M, Alizon S, Epidemiological feedbacks affect evolutionary emergence of pathogens. Am Nat. 2014;183(4):E105–17. doi: 10.1086/674795 24642501
27. Urbanowicz RA, McClure CP, Sakuntabhai A, Sall AA, Kobinger G, Müller MA, et al. Human adaptation of Ebola virus during the West African outbreak. Cell. 2016;167(4):1079–1087. doi: 10.1016/j.cell.2016.10.013 27814505
28. Diehl WE, Lin AE, Grubaugh ND, Carvalho LM, Kim K, Kyawe PP, et al. Ebola virus glycoprotein with increased infectivity dominated the 2013–2016 epidemic. Cell. 2016;167(4):1088–1098.e6. doi: 10.1016/j.cell.2016.10.014 27814506
29. Liu Y, Liu J, Du S, Shan C, Nie K, Zhang R, et al. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature. 2017;545(7655):482–486. doi: 10.1038/nature22365 28514450
30. Day T, Proulx SR, A general theory for the evolutionary dynamics of virulence. Am Nat. 2004;163(4):E40–E63. doi: 10.1086/382548 15122509
31. Alizon S, A visionary pioneer of parasite ecology and evolution. Am Nat. 2016;187. doi: 10.1086/686526 27172602
32. Méthot PO, Why do parasites harm their host? On the origin and legacy of Theobald Smith's 'Law of declining virulence'—1900–1980. Hist Phil Life Sci. 2012;34:561–601.
33. Anderson W, Natural histories of infectious disease: Ecological vision in twentieth-century biomedical science. Osiris. 2004;19(1):39–61. doi: 10.1086/649393
34. Mendelsohn JA, From eradication to equilibrium: how epidemics became complex after World War I. In: Greater than the parts: Holism in biomedicine, 1920–1950. Oxford Univ. Press; 1998. p. 303–331.
35. Lewontin RC, The units of selection. Annu Rev Ecol Syst. 1970; doi: 10.1146/annurev.es.01.110170.000245
36. Anderson RM, May RM, Coevolution of hosts and parasites. Parasitology. 1982;85:411–426. 6755367
37. Ewald PW, Host-parasite relations, vectors, and the evolution of disease severity. Annu Rev Ecol Evol Syst. 1983;14:465–485. doi: 10.1146/annurev.es.14.110183.002341
38. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP, Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA. 2007;104(44):17441–17446. doi: 10.1073/pnas.0708559104 17954909
39. Fraser C, Lythgoe K, Leventhal GE, Shirreff G, Hollingsworth TD, Alizon S, et al. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science. 2014;343(6177):1243727. doi: 10.1126/science.1243727 24653038
40. Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, et al. Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. PLoS Biol. 2017;15(6):e2001855. doi: 10.1371/journal.pbio.2001855 28604782
41. Alizon S, Michalakis Y, Adaptive virulence evolution: the good old fitness-based approach. Trends Ecol Evol. 2015;30(5):248–254. doi: 10.1016/j.tree.2015.02.009 25837917
42. Berngruber TW, Froissart R, Choisy M, Gandon S, Evolution of virulence in emerging epidemics. PLoS Pathog. 2013;9(3):e1003209. doi: 10.1371/journal.ppat.1003209 23516359
43. Hawley DM, Osnas EE, Dobson AP, Hochachka WM, Ley DH, Dhondt AA, Parallel patterns of increased virulence in a recently emerged wildlife pathogen. PLoS Biol. 2013;11(5):e1001570. doi: 10.1371/journal.pbio.1001570 23723736
44. Butler CC, Kinnersley P, Prout H, Rollnick S, Edwards A, Elwyn G, Antibiotics and shared decision-making in primary care. J Antimicrob Chemother. 2001;48:435–440. doi: 10.1093/jac/48.3.435 11533013
45. Kennedy DA, Read AF, Why does drug resistance readily evolve but vaccine resistance does not?Proc B. 2017;284(1851):20162562. doi: 10.1098/rspb.2016.2562 28356449
46. Gandon S, Day T, Evidences of parasite evolution after vaccination. Vaccine. 2008;26S:C4–7. doi: 10.1016/j.vaccine.2008.02.007
47. Ewald PW, Evolutionary medicine: A synthesis in progress. Quart Rev Biol. 2009;84(1):75–80. doi: 10.1086/596464
48. Gandon S, Mackinnon MJ, Nee S, Read AF, Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414:751–756. doi: 10.1038/414751a 11742400
49. Barclay VC, Sim D, Chan BHK, Nell LA, Rabaa MA, Bell AS, et al. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol. 2012;10(7):e1001368. doi: 10.1371/journal.pbio.1001368 22870063
50. Nair V, Evolution of Marek's disease–a paradigm for incessant race between the pathogen and the host. Vet J. 2005;170(2):175–83. doi: 10.1016/j.tvjl.2004.05.009 16129338
51. Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L, Smith LP, et al. Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol. 2015;13(7):e1002198. doi: 10.1371/journal.pbio.1002198 26214839
52. Goossens H, Ferech M, Stichele RV, Elseviers M, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–587. doi: 10.1016/S0140-6736(05)17907-0 15708101
53. Bud R, Penicillin: triumph and tragedy. Oxford University Press; 2007.
54. Dubos RJ, The evolution of infectious diseases in the course of history. Canadian Medical Association Journal. 1958;79(6):445–451. 13573300
55. Lederberg J, Infectious history. Science. 2000;288(5464):287–293. 10777411
56. Casadevall A, Pirofski LA, Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 1999;67(8):3703–13. 10417127
57. Schmid-Hempel P, Evolutionary Parasitology: The integrated study of infections, immunology, ecology, and genetics. Oxford, UK: Oxford Univ Press; 2011.
58. Baquero F, Blázquez J, Evolution of antibiotic resistance. Trends Ecol Evol. 1997;12:482–487. 21238165
59. Bonhoeffer S, Lipsitch M, Levin BR, Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA. 1997;94:12106–12111. 9342370
60. Pena-Miller R, Laehnemann D, Jansen G, Fuentes-Hernandez A, Rosenstiel P, Schulenburg H, et al. When the most potent combination of antibiotics selects for the greatest bacterial load: The smile-frown transition. PLoS Biol. 2013;11(4):e1001540. doi: 10.1371/journal.pbio.1001540 23630452
61. Fuentes-Hernandez A, Plucain J, Gori F, Pena-Miller R, Reding C, Jansen G, et al. Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages. PLoS Biol. 2015;13(4):e1002104. doi: 10.1371/journal.pbio.1002104 25853342
62. McGowan JE, Minimizing antimicrobial resistance in hospital bacteria: Can switching or cycling drugs help?Infection Control. 1986;7(12):573–576. 3539850
63. Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM, The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2009;106(34):14711–14715. doi: 10.1073/pnas.0902437106 19706556
64. Kouyos RD, Abel Zur Wiesch P, Bonhoeffer S, On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community. PLoS Pathog. 2011;7(4):e1001334. doi: 10.1371/journal.ppat.1001334 21533212
65. Ehrlich P, Address in pathology on chemotherapeutics: Scientific principles, methods, and results. Lancet. 1913;182(4694):445–451. doi: 10.1016/S0140-6736(01)38705-6
66. Hansen E, Woods RJ, Read AF, How to use a chemotherapeutic agent when resistance to it threatens the patient. PLoS Biol. 2017;15(2):e2001110. doi: 10.1371/journal.pbio.2001110 28182734
67. CLL Trialists' CollaborativeGroupChemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials. J Natl Cancer Inst. 1999;91(10):861–868. doi: 10.1093/jnci/91.10.861 10340906
68. Day T, Huijben S, Read AF, Is selection relevant in the evolutionary emergence of drug resistance?Trends Microbiol. 2015;23(3):126–133. doi: 10.1016/j.tim.2015.01.005 25680587
69. Antonovics J, Abbate JL, Baker CH, Daley D, Hood ME, Jenkins CE, et al. Evolution by any other name: antibiotic resistance and avoidance of the E-word. PLoS Biol. 2007;5(2):e30. doi: 10.1371/journal.pbio.0050030 17298172
70. Méthot PO, Darwin, evolution, and medicine: Historical and contemporary perspectives. In: Handbook of evolutionary thinking in the sciences. Springer; 2015. p. 587–617.
71. Latour B, The pasteurization of France. Cambridge (MA), USA: Harvard University Press; 1993.
72. Tracy SW, George Draper and American constitutional medicine, 1916–1946: reinventing the sick man. Bull Hist Med. 1992;66(1):53–89. 1559029
73. Kevles DJ, In the name of eugenics: Genetics and the uses of human heredity. Harvard University Press; 1995.
74. Zampieri F, Medicine, evolution, and natural selection: an historical overview. Q Rev Biol. 2009;84(4):333–55. 20039527
75. Smocovitis VB, Unifying biology: The evolutionary synthesis and evolutionary biology. Princeton: Princeton University Press; 1996.
76. O’Malley MA, Ernst Mayr, the tree of life, and philosophy of biology. Biol Philos. 2014;25(4):529–552. doi: 10.1007/s10539-010-9214-6
77. Méthot PO, Bacterial transformation and the origins of epidemics in the interwar period: The epidemiological significance of Fred Griffith’s ‘transforming experiment’. J Hist Biol. 2016;49(2):311–358. doi: 10.1007/s10739-015-9415-6 26294287
78. Gradmann C., From lighthouse to hothouse: Hospital hygiene, antibiotics and the evolution of infectious disease, 1950–1990. Hist Phil Life Sci. 2018. doi: 10.1007/s40656-017-0176-8 29181597
79. Williams GC, Nesse RM, The dawn of Darwinian medicine. Q Rev Biol. 1991;66(1):1–22. 2052670
80. Nesse RM, Stearns SC, The great opportunity: evolutionary applications to medicine and public health. Evolutionary Applications. 2008;1(1):28–48. doi: 10.1111/j.1752-4571.2007.00006.x 25567489
81. Cournoyea M, Ancestral assumptions and the clinical uncertainty of evolutionary medicine. Perspect Biol Med. 2013;56(1):36–52. doi: 10.1353/pbm.2013.0006 23748525
82. Valles SA, Evolutionary medicine at twenty: rethinking adaptationism and disease. Biol Philos. 2012;27(2):241–261. doi: 10.1007/s10539-011-9305-z
83. Perlman Robert L, Evolution and medicine. Oxford: Oxford University Press; 2013.
84. Murall CL, McCann KS, Bauch CT, Food webs in the human body: linking ecological theory to viral dynamics. PLoS ONE. 2012;7(11):e48812. doi: 10.1371/journal.pone.0048812 23155409
85. Bell G, Gouyon PH, Arming the enemy: the evolution of resistance to self-proteins. Microbiology. 2003;149:1367–1375. doi: 10.1099/mic.0.26265-0 12777478
86. Beceiro A, Tomás M, Bou G, Antimicrobial resistance and virulence: A successful or deleterious association in the bacterial world?Clin Microbiol Rev. 2013;26(2):185–230. doi: 10.1128/CMR.00059-12 23554414
87. Van Baalen M, Coevolution of recovery ability and virulence. Proc R Soc Lond B. 1998;265:317–325. doi: 10.1098/rspb.1998.0298 9523434
88. Honigsbaum M, René Dubos, tuberculosis, and the ecological facets of virulence. Hist Phil Life Sci. 2017;39(3):15. doi: 10.1007/s40656-017-0142-5 28677044
89. zur Wiesch PA, Kouyos R, Engelstädter J, Regoes RR, Bonhoeffer S, Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis. 2011;11(3):236–47. doi: 10.1016/S1473-3099(10)70264-4 21371657
90. Hauser AR, Mecsas J, Moir DT, Beyond antibiotics: New therapeutic approaches for bacterial infections. Clin Infect Dis. 2016;63(1):89–95. doi: 10.1093/cid/ciw200 27025826